Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

8 Mar 2026

AUTH/3560/9/21: Anonymous health professional complaint about pressure to sign up to diabetes review service (No breach) – Sanofi

Anonymous nurse alleged a Sanofi account executive pressured them to sign up to a diabetes therapy review service…

8 Mar 2026

AUTH/3482/3/21: Complainant v GlaxoSmithKline (LinkedIn post about Nucala) – Out of scope of the ABPI Code

A complaint alleged promotion of Nucala (mepolizumab) on LinkedIn. The PMCPA recorded the case as outwith the scope…

8 Mar 2026

Tetris Pharma: LinkedIn sponsored message for Ogluo reached a non-HCP (public promotion) and lacked required safety/INN elements

A LinkedIn sponsored message promoting Ogluo (glucagon) was received by a non-HCP. The Panel found public promotion plus…

8 Mar 2026

Ipsen voluntary admission: employee promoted to HCPs in Northern Ireland without verified ABPI representative exam (AUTH/3839/10/23)

Ipsen admitted an employee in a promotional role in Northern Ireland had no verified ABPI representative exam on…

8 Mar 2026

AUTH/3885/3/24: Ever Pharma UK v Britannia Pharmaceuticals – off-licence promotion risk via nurse service package deal and sponsored symposium

PMCPA found Britannia breached Clauses 11.2 and 5.1 after its nurse service package deal agreement contemplated home initiation…

8 Mar 2026

AUTH/2147/7/08: GlaxoSmithKline v Sanofi Pasteur MSD – Gardasil press release and PR agency emails

A Gardasil press release and follow-up PR emails after the UK chose Cervarix for the national HPV programme…

8 Mar 2026

Anonymous v GlaxoSmithKline: POINTS COPD audit service (AUTH/2178/10/08) – No breach

Anonymous complaint questioned GSK’s POINTS COPD audit service as a potential rep monitoring/inducement tool. Panel found clear separation…

8 Mar 2026

AUTH/2198/10/9: Primary Care Trust v Solvay β€” Not stated

PMCPA case summary for AUTH/2198/10/9 (Primary Care Trust v Solvay). The provided case text contains no details on…

8 Mar 2026

Otsuka Europe voluntary admission: unclear SPC update communications for Jinarc and out-of-date package leaflet (AUTH/3169/3/19)

Otsuka Europe admitted potential Code issues after confusing affiliate communications on parallel Jinarc SPC variations and an out-of-date…

8 Mar 2026

Sanofi-Aventis: HSJ β€˜special report’ found to be disguised promotion for dronedarone (Clause 12.1)

A sponsored HSJ β€˜special report’ on atrial fibrillation looked like independent editorial and favoured dronedarone. PMCPA ruled Sanofi-Aventis…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training